Tech Company Financing Transactions

Prematics Funding Round

On 4/28/2008, Prematics landed Series B funding from Health Evolution Partners, Foundation Capital and General Catalyst Partners.

Transaction Overview

Company Name
Prematics
Announced On
4/28/2008
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors

Health Evolution Partners (Lead Investor) (David Brailer)

Foundation Capital (Richard Redelfs)

General Catalyst Partners (Ken Novack)

Proceeds Purpose
The investment will advance expanded deploymentof Prematics' distinct medication management system, ScriptToneSM, in partnership withhealth plans. ScriptTone supports physician acceptance of electronic prescribing through ano-cost, all-inclusive managed service model.

Company Information

Company Status
Acquired or Merged
Industry
Healthcare Services
Mailing Address
8230 Leesburg Pike 700
Vienna, VA 22182
USA
Phone
(703) 956-5500
Website
www.prematics.com
Email Address
[email protected]
Overview
Prematics built an inter-disciplinary team to drive the mass adoption of electronic prescribing. The team is comprised of industry leaders representing the key stakeholders in the prescription process, including physicians, payors, pharmacy benefits managers, and retail pharmacies.
Profile
Prematics LinkedIn Company Profile
Social Media
Prematics Company Twitter Account
Company News
Prematics News
Facebook
Prematics on Facebook
YouTube
Prematics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kevin Hutchinson
  Kevin Hutchinson LinkedIn Profile  Kevin Hutchinson Twitter Account  Kevin Hutchinson News  Kevin Hutchinson on Facebook
Chief Medical Officer
Michael Ross
  Michael Ross LinkedIn Profile  Michael Ross Twitter Account  Michael Ross News  Michael Ross on Facebook
Vice President
Michael Russo
  Michael Russo LinkedIn Profile  Michael Russo Twitter Account  Michael Russo News  Michael Russo on Facebook
VP - Product Management
David Kates
  David Kates LinkedIn Profile  David Kates Twitter Account  David Kates News  David Kates on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/28/2008: ReliOn venture capital transaction
Next: 4/28/2008: SurgRx venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.